(Press-News.org) TUCSON, Ariz., November 7, 2024 — Critical Path Institute® (C-Path) today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as the new Executive Director of C-Path’s Critical Path for Alzheimer’s Disease (CPAD) Consortium.
With over 30 years of specialized research in neuroscience and drug development and having served as the Executive Director of the Critical Path for Parkinson’s Consortium (CPP) for nearly 15 years, Dr. Stephenson has been an extraordinary partner in advancing our understanding of neurodegenerative diseases such as Alzheimer’s (AD), and Parkinson’s (PD) diseases. Her leadership in spearheading the progress of CPP through collaboration across all stakeholders has broadened treatment pathways and deepened scientific knowledge in these areas.
As Vice President of Neurology, Dr. Stephenson will continue to guide C-Path’s initiatives for brain health, applying her expertise in neuroimaging, neuropathology, digital health technologies and translational model characterization to further C-Path’s research objectives. Importantly, she will continue to serve as Executive Director of CPP, ensuring ongoing strategic alignment with C-Path’s mission.
“It is a great privilege to advance my career at C-Path, an organization at the forefront of developing treatments for neurodegenerative diseases,” said Stephenson. “I am looking forward to this new chapter, where I will continue to build upon our collective expertise across academia, industry, and regulatory bodies to deepen our impact on patient care.”
Dr. Nadine Tatton brings more than two decades of expertise in drug development, strategic leadership, and neurodegenerative disease research to her new role as Executive Director of CPAD. Dr. Tatton earned her Ph.D. in physiology (neuroscience) from the University of Toronto and pursued postdoctoral studies in spinal cord research and molecular neuroscience. Over her career, she has held leadership roles in both academic and industry settings where she advanced clinical programs for diseases like AD, frontotemporal dementia (FTD) and PD.
Prior to joining C-Path, Tatton served as Medical Director, Immuno-Neurology at Alector, Inc., where she worked on novel therapeutic approaches targeting neurodegenerative diseases. Her extensive experience also includes her role as Scientific Director at the Association for Frontotemporal Degeneration where she spearheaded collaborative partnerships to advance research on FTD disorders and helped build the FTD Disorders Registry. Dr. Tatton’s diverse background uniquely positions her to lead CPAD in its mission to foster innovative regulatory science that accelerates drug development for AD.
“I am honored to join C-Path and to lead the CPAD Consortium in its mission to drive therapeutic innovation for Alzheimer’s disease,” said Dr. Tatton. “There is so much momentum in AD research today, and I look forward to working with our global collaborators across industry, regulatory agencies, and academia to push the boundaries of what is possible in Alzheimer’s drug development.”
C-Path CEO, Klaus Romero , M.D., M.S., FCP, also shared his excitement about the appointments, stating, “Dr. Stephenson’s promotion to Vice President of Neurology aligns with C-Path’s strategy to buttress our collaborative approach for continued innovation in tools that can further accelerate drug development for neurodegeneration. As Executive Director of CPAD, Dr. Tatton will enable C-Path to launch new initiatives and further strengthen our core capabilities in data-driven collaboration to accelerate drug development in AD. Their leadership is crucial as we continue to advance tools and strategies that address the unmet challenges in neurodegenerative research.”
Both appointments are effective immediately, with Drs. Stephenson and Tatton continuing their important work in neurology, Parkinson’s and Alzheimer’s disease research with key focus on patient-centered strategies.
For more information on C-Path’s neurology efforts, visit, https://c-path.org/area-of-focus/neuroscience/.
About Critical Path Institute
Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.
Critical Path Institute is supported by the Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) and is 56% funded by the FDA/HHS, totaling $23,740,424, and 44% funded by non-government source(s), totaling $18,881,611. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. Government.
END
C-Path announces key leadership appointments in neurodegenerative disease research
Dr. Diane Stephenson promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as new Executive Director of CPAD
2024-11-08
ELSE PRESS RELEASES FROM THIS DATE:
First-of-its-kind analysis of U.S. national data reveals significant disparities in individual well-being as measured by lifespan, education, and income
2024-11-08
First-of-its-kind analysis of US national data reveals significant disparities in individual well-being as measured by lifespan, education, and income.
White males make up largest share of the group with lowest well-being while American Indian and Alaska Native individuals, and Black males, face the most significant challenges to overall well-being.
Populations at the lowest levels of well-being across the US are especially concentrated in the Deep South, Appalachia, and the Rust Belt.
The ...
Exercise programs help cut new mums’ ‘baby blues’ severity and major depression risk
2024-11-08
Exercise-only programmes help cut the severity of the ‘baby blues’ and the risk of major clinical depression in new mums, finds a pooled data analysis of the available evidence, published in the British Journal of Sports Medicine.
But at least 80 weekly minutes of moderate intensity exercise, such as brisk walking, water aerobics, stationary cycling, and resistance training with bands, weights, or body weight are needed to achieve the effects, the findings show.
Maternal depression and anxiety are relatively common after giving birth and associated with reduced self-care and compromised infant caregiving and bonding, ...
Gut microbiome changes linked to onset of clinically evident rheumatoid arthritis
2024-11-08
Changes in the make-up of the gut microbiome are linked to the onset of clinically evident rheumatoid arthritis in those at risk of the disease because of genetic, environmental, or immunological factors, suggests research published online in the Annals of the Rheumatic Diseases.
It’s not clear if this instability is a cause or consequence of disease development, emphasise the researchers, but the findings might nevertheless help to identify those at risk as well as paving the way for preventive and personalised treatment strategies, they suggest.
Previously published research consistently shows an unfavourable imbalance in ...
Signals from the gut could transform rheumatoid arthritis treatment
2024-11-08
Changes in the gut microbiome before rheumatoid arthritis is developed could provide a window of opportunity for preventative treatments, new research suggests.
Bacteria associated with inflammation is found in the gut in higher amounts roughly ten months before patients develop clinical rheumatoid arthritis, a longitudinal study by Leeds researchers has found.
Affecting more than half a million people in the UK, rheumatoid arthritis is a chronic disease that causes swelling, pain and stiffness in the ...
Pioneering research reveals some of the world’s least polluting populations are at much greater risk of flooding fuelled by climate change
2024-11-08
A new study has exposed for the first time how inhabitants of the smallest countries globally, contributing least to climate change, already bear the brunt of its devastating consequences and the burden is likely to worsen.
The research, led by the University of Bristol, showed on average nearly one in five people (20%) in Small Island Developing States (SIDS) – totalling some 8.5million – are now exposed to coastal and inland flooding. For three of the 57 countries concentrated in the Pacific, Caribbean, Indian Ocean, ...
UK’s health data should be recognized as critical national infrastructure, says independent review
2024-11-08
An independent review, Uniting the UK’s Health Data: A Huge Opportunity for Society, published today (8 November 2024), has found that complexities and inefficiencies are impeding the use of the UK’s rich sources of health data to improve people’s health and lives. Researchers and analysts frequently have to wait many months – or even years – to securely access health data to improve care and for vital research into diseases like dementia, cancer and heart disease.
Led by Professor ...
A 36-gene predictive score of anti-cancer drug resistance anticipates cancer therapy outcomes
2024-11-07
BIRMINGHAM, Ala. – In 1937, President Franklin Roosevelt signed the National Cancer Act, launching a nationwide effort to combat the disease. Eighty-seven years later, despite significant progress, cancer treatment often falls short, with 50 to 80 percent of patients not responding to treatment and more than 600,000 cancer deaths annually in the United States.
What if clinicians could predict the success of any cancer treatment, ensuring each patient receives the most effective care?
The challenge lies in the diverse nature of the disease. There are hundreds of different types of cancers, characterized by the specific type of cell from which they originate. Even patients ...
Someone flirts with your spouse. Does that make your partner appear more attractive?
2024-11-07
Picture this: You’re at a bar when someone starts hitting shamelessly on your spouse or significant other, who doesn’t flirt back. As the scene unfolds, your base instincts kick in—annoyance, anger, jealousy—followed by a heightened sexual desire for your partner. You’re ready to reclaim the attention that should be rightfully yours, correct?
Not necessarily, according to a new study in the Journal of Sex Research by researchers at Reichman University in Herzliya, Israel, and ...
Hourglass-shaped stent could ease severe chest pain from microvascular disease
2024-11-07
ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in people with microvascular disease. Of 30 participants in a phase 2 clinical trial, 76% saw improvement in their day-to-day life. For example, some participants who reported not being able to walk around the block or up a flight of stairs without chest pain were able to do these ordinary physical activities at the end of a 120-day period. Clinical measures of blood flow related to the microvasculature of the heart significantly improved during ...
United Nations ratifies framework to protect people on cash app
2024-11-07
As mobile-money services were growing at a rapid clip in the developing world 10 years ago, University of Florida computer scientists and cybersecurity experts Kevin Butler and Patrick Traynor were early sentinels, raising concerns about the lack of security that could lead to real problems for the user.
In a 2014 study, the two professors from UF’s Department of Computer and Information Science and Engineering, uncovered security vulnerabilities of mobile cash apps, especially in the Global South, where such technologies were becoming essential in the absence of robust banking systems.
“Our early work uncovered ...
LAST 30 PRESS RELEASES:
Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac
CIDEC as a novel player in abdominal aortic aneurysm formation
Artificial intelligence: a double-edged sword for the environment?
Current test accommodations for students with blindness do not fully address their needs
Wide-incident-angle wideband radio-wave absorbers boost 5G and beyond 5G applications
A graph transformer with boundary-aware attention for semantic segmentation
C-Path announces key leadership appointments in neurodegenerative disease research
First-of-its-kind analysis of U.S. national data reveals significant disparities in individual well-being as measured by lifespan, education, and income
Exercise programs help cut new mums’ ‘baby blues’ severity and major depression risk
Gut microbiome changes linked to onset of clinically evident rheumatoid arthritis
Signals from the gut could transform rheumatoid arthritis treatment
Pioneering research reveals some of the world’s least polluting populations are at much greater risk of flooding fuelled by climate change
UK’s health data should be recognized as critical national infrastructure, says independent review
A 36-gene predictive score of anti-cancer drug resistance anticipates cancer therapy outcomes
Someone flirts with your spouse. Does that make your partner appear more attractive?
Hourglass-shaped stent could ease severe chest pain from microvascular disease
United Nations ratifies framework to protect people on cash app
Oklahoma State basketball team joins the Nation of Lifesavers
Power of aesthetic species on social media boosts wildlife conservation efforts, say experts
Researchers develop robotic sensory cilia that monitor internal biomarkers to detect and assess airway diseases
Could crowdsourcing hold the key to early wildfire detection?
Reconstruction of historical seasonal influenza patterns and individual lifetime infection histories in humans based on antibody profiles
New study traces impact of COVID-19 pandemic on global movement and evolution of seasonal flu
Presenting a Janus channel of membranes for complete oil-and-water separation
COVID-19 restrictions altered global dispersal of influenza viruses
Disconnecting hepatic vagus nerve restores balance to liver and brain circadian clocks, reducing overeating in mice
Mechanosensory origins of “wet dog shakes” – a tactic used by many hairy mammals – uncovered in mice
New study links liver-brain communication to daily eating patterns
Defense or growth – How plants allocate resources
Study identifies hip implant materials with the lowest risk of needing revision
[Press-News.org] C-Path announces key leadership appointments in neurodegenerative disease researchDr. Diane Stephenson promoted to Vice President of Neurology; Dr. Nadine Tatton Welcomed as new Executive Director of CPAD